OncoSec Medical Inc (ONCSQ)

[akhsv777]

Based on ONCS current valuation and near term catalysts, the upside case and path to it are pretty straightforward.

It is rare to find a bio company trading at this ONCS's current level that has not suffered some major setbacks, i.e. a failed clinical trial, a regulatory setback....

on the contrast, ONCS has continued to generate positive data, enhancing management team and sharpen development focus.

Speaking sharpen development focus - ONCS is a tiny ~$80M MC company with limited resources ($+H/C). Having say that, they just can't be pulled all directions like resource rich multi billion $ companies. I realized some of us are disappointed over limited pipeline and limited company focus but IMO, ONCS should focus to get through the 1st big milestone with their core program first.....I am happy to see ONCS'S new mgmt team is on a same page.